TCM — TCM A/S Income Statement
0.000.00%
- DKK681.89m
- DKK1.06bn
- DKK1.28bn
- 73
- 87
- 40
- 78
Annual income statement for TCM A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,108 | 1,146 | 1,084 | 1,204 | 1,279 |
| Cost of Revenue | |||||
| Gross Profit | 255 | 234 | 216 | 255 | 290 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 970 | 1,049 | 1,038 | 1,113 | 1,163 |
| Operating Profit | 138 | 96.9 | 45.8 | 90.3 | 116 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 136 | 89.4 | 27.1 | 69.4 | 93.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 111 | 70.5 | 21.5 | 57.7 | 77.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 111 | 70.5 | 21.5 | 57.7 | 77.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 111 | 70.5 | 21.5 | 57.7 | 77.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 12 | 8.34 | 3.27 | 5.52 | 7.7 |
| Dividends per Share |